Preparing for weight-loss surgery with tirzepatide, keto diet, or standard care
Part of Heart & circulation, Hormones & metabolism clinical trials.
This trial is testing two ways to prepare for weight-loss surgery: a medication called tirzepatide (Mounjaro) or a keto diet. Both are compared to standard care to see which helps improve health before the operation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- Your BMI is between 40 and 55 (a measure of body size based on height and weight).
- You have at least one weight-related health problem, like type 2 diabetes, high blood pressure, high cholesterol, or sleep apnea.
- You have not had weight-loss surgery or major stomach surgery in the past.
- You have not used certain diabetes or weight-loss medications (like Ozempic, Mounjaro, or Wegovy) in the last 12 months.
- You are not pregnant, planning to become pregnant soon, or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medication called tirzepatide (a daily injection) to help people who haven't lost enough weight after weight-loss surgery. If you fit the criteria, the medication may help you lose more weight healthily.
This study tests whether combining a weight-loss medication called tirzepatide (also known as Mounjaro) with a supervised exercise program helps people lose weight and improve their overall health. You'll be in the study for about four months, and you'll get support and monitoring.
This trial studies bariatric (weight-loss) surgery and how well it helps people reach and keep a healthier weight. You may qualify if you have severe obesity and have not been able to maintain weight loss with other attempts, and if you can safely follow the study plan.
This study tests whether giving tirzepatide (a medicine that helps with weight and blood sugar) right after weight loss surgery can improve results. It is for people who are already scheduled for sleeve gastrectomy or gastric bypass at UK HealthCare.
This study tests a new drug, NA-931, combined with an existing weight-loss medication (tirzepatide) to see if they work well and are safe for adults who are overweight or obese. It may help you lose weight and improve health conditions related to excess weight.
This trial tests the weight‑loss medication tirzepatide (Mounjaro) in people who are overweight or have obesity and have stable coronary artery disease. The goal is to see if tirzepatide can reduce dangerous fatty plaque in heart arteries.
Hear when a new Obesity (BMI > 35) and Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.